The Prevent Coronary Artery Disease Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1600 participants.

Also called NCT06494501

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 1,600 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06494501
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06494501. Randomized; no masking; primary purpose prevention. Start 2024-09-12 (actual); primary completion 2032-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Prevent Coronary Artery Disease Trial
Acronym
PRECAD
Condition
Atherosclerotic Cardiovascular Disease
Intervention (Drug)
Inclisiran
Lead sponsor
Icahn School of Medicine at Mount Sinai (class: other)

Record details

Record id
cardio:ct-nct06494501
Content hash
2d1fb2fae699afe5062fa4dcd167f813eeea7c845befdd2b82447795a5a8a25a